Cancer Medicines & Precision Diagnostics

Own the cancer-treatment ecosystem, spanning established oncology franchises, investigational therapies and molecular diagnostics that guide treatment selection. The basket combines commercial drug revenue with exposure to personalized cancer vaccines and engineered cell therapies. This is a structural oncology allocation rather than a trade dependent on a fresh headline. Launch basket (equal weight): MRK, ABBV, AMGN, LLY, MRNA, REGN, INCY, BEAM, CRSP, TEM Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.